Ivermectin (off-label uses)
Ivermectin
Ivermectin is a Nobel Prize–winning antiparasitic — genuinely lifesaving for strongyloides, onchocerciasis, scabies, and lice. For COVID-19, the rigorous human trials (TOGETHER, PRINCIPLE) found no meaningful benefit. We cover both indications honestly.
Avermectin / antiparasiticPrescription requiredEvidence D
⚠ Not medical advice.Not medical advice. This page is educational. Discuss with your physician before starting, changing, or stopping any medication.
Why it matters
Ivermectin deserves a careful, two-sided telling. For the indications it is approved for — strongyloidiasis, onchocerciasis (river blindness), scabies, head lice, lymphatic filariasis — it is one of the safest and most consequential drugs of the 20th century. The 2015 Nobel Prize in Physiology or Medicine recognized William Campbell and Satoshi Omura for ivermectin's impact on global parasitic disease. Crump and Omura's reviews lay out the mechanism (glutamate-gated chloride channel binding in invertebrates) and the scale of the public health impact. For unapproved indications — COVID-19, cancer, general anti-inflammatory use — the picture is different. Caly et al. (2020) showed in vitro activity against SARS-CoV-2, but at concentrations roughly 50–100x what is achievable with safe human dosing. The rigorous human RCTs that followed — TOGETHER (Reis et al., NEJM 2022) and PRINCIPLE — found no clinically meaningful benefit for COVID-19. The Cochrane Review concluded the same. Major medical societies, the FDA, and WHO do not recommend ivermectin for COVID-19. The drug is excellent for parasites. It is not a general-purpose antiviral or longevity agent at human-safe doses. Evidence grade: A for approved parasitic uses; D for non-parasitic off-label indications.
Uses
Label uses (approved)
- Strongyloidiasis
- Onchocerciasis (river blindness)
- Scabies (topical and oral)
- Head lice
- Filariasis
Dosing
Label dose
150–200 mcg/kg single oral dose (most parasitic indications)
Off-label / biohacker dose
For COVID-19 (NOT RECOMMENDED): trial doses ranged 200–600 mcg/kg, often daily for 3 days. Not endorsed by any major guideline body.
Titration: For approved parasitic indications, single doses are typical. Off-label regimens for COVID-19 or other non-parasitic uses lack validated protocols.
When to take: Single dose with water; food may affect bioavailability — follow indication-specific guidance
Side effects & warnings
Common
- GI upset
- Dizziness
- Pruritus
- Rash (especially in onchocerciasis — Mazzotti reaction)
- Headache
Uncommon but serious
- Encephalopathy (in patients with high Loa loa burden)
- Hypotension
- Hepatic enzyme elevation
Serious warnings
Veterinary-formulation ivermectin (livestock paste, injectable, pour-on) is NOT for human use — concentrations are much higher and excipients are inappropriate. Serious toxicity including coma has been reported with veterinary product self-dosing. For approved human use, ivermectin is exceptionally safe. For unapproved indications (COVID-19, cancer), the risk-benefit equation flips — you take on side effect risk for benefit not established in rigorous human trials.
Biomarkers affected
Monitoring
For approved indications, typically minimal. For off-label chronic use, liver function tests are reasonable.
The honest risk picture
## Realistic risks of off-label ivermectin
**This entry covers OFF-LABEL use only.** For approved parasitic indications (strongyloides, onchocerciasis, scabies, lice), ivermectin is one of the safest drugs in the pharmacopeia, with a Nobel Prize–level evidence base.
**For COVID-19, the rigorous evidence is negative.** Not "mixed" — negative. The TOGETHER trial (Reis et al., NEJM 2022, n=3,515) found no significant reduction in hospitalization or death. PRINCIPLE (Hayward et al., 2024, n=8,811) confirmed the same in outpatients. The Cochrane Review (Popp et al., 2022) reviewed all available data and concluded there is no evidence of meaningful benefit and called for an end to non-rigorous trials. Many of the small earlier "positive" trials that drove enthusiasm have been retracted or shown to have data integrity problems (most notoriously the Elgazzar Egyptian trial).
**In vitro is not in vivo:** The Caly 2020 paper showed in vitro activity against SARS-CoV-2 — but at concentrations roughly 50–100x what is achievable in human plasma at safe doses. This is the central mistake in the "ivermectin for COVID" narrative.
**Veterinary product is dangerous:** Livestock paste, pour-on, and injectable ivermectin are NOT for humans. Concentrations are much higher; excipients are inappropriate. Hospitalizations, comas, and at least one death have been reported.
**Other off-label uses:** Cancer, "general anti-inflammatory" — no quality human evidence. In vitro signal at supraphysiologic concentrations does not equal clinical efficacy.
**Drug interactions:** Ivermectin is a CYP3A4 substrate and P-glycoprotein substrate. Interactions with warfarin, antifungals, and certain anticonvulsants are documented.
**The honest framing:** If you have a parasitic indication, ivermectin is a miracle. If you are taking it for COVID-19 in 2026, the rigorous evidence does not support that use. PrimalPrime recommends following major medical society guidance — not Telegram channels.
Practical context
Cost (US, retail)
$20/mo
Legality
Prescription medication in the US for human-approved indications. Telehealth providers prescribe off-label for COVID-19 in some states. Veterinary product is sold over-the-counter at feed stores — IT IS NOT SAFE for human consumption.
Interactions
true
FAQ
Does ivermectin work for COVID-19?+
The two largest rigorous randomized trials — TOGETHER (Reis et al., NEJM 2022) and PRINCIPLE — found no clinically meaningful benefit for COVID-19. The Cochrane Review concluded there is no evidence of benefit and called for an end to non-rigorous trials. In vitro signal exists but only at concentrations 50–100x what is achievable with safe human dosing. The FDA, WHO, and major medical societies do not recommend ivermectin for COVID-19.
What does ivermectin actually work for?+
A lot. Strongyloidiasis, onchocerciasis (river blindness), scabies, head lice, lymphatic filariasis. The 2015 Nobel Prize recognized Campbell and Omura for ivermectin's contribution to global health. For these indications, ivermectin is one of the most important and safe drugs in modern medicine.
Is veterinary ivermectin safe?+
No. Livestock ivermectin paste and injectable formulations are much more concentrated than human dosing and contain excipients not safe for human consumption. Hospitalizations and at least one coma have been reported from self-dosing veterinary product. If you have a legitimate parasitic indication, get a human prescription.
References (5)+
- Effect of Early Treatment with Ivermectin among Patients with COVID-19 — TOGETHER Trial (Reis et al., NEJM 2022). . https://pubmed.ncbi.nlm.nih.gov/35353979/
- Effectiveness of Ivermectin in COVID-19 — PRINCIPLE Trial (Hayward et al., 2024 / Lancet Respir Med). . https://pubmed.ncbi.nlm.nih.gov/38432235/
- Ivermectin — A Review of Its Antiparasitic Activity and Global Impact (Crump & Omura, Proc Jpn Acad Ser B 2011). . https://pubmed.ncbi.nlm.nih.gov/21321478/
- The FDA-Approved Drug Ivermectin Inhibits SARS-CoV-2 In Vitro (Caly et al., Antiviral Res 2020). . https://pubmed.ncbi.nlm.nih.gov/32251768/
- Cochrane Review: Ivermectin for Preventing and Treating COVID-19 (Popp et al., 2022). . https://pubmed.ncbi.nlm.nih.gov/35726131/
The prime report
Weekly performance intelligence.
New studies, protocols, and optimization frameworks delivered every Monday. No fluff, no motivation quotes — only what moves the needle.